Top Story

VIDEO: Discussion of the benefits, risks of extended DAPT

December 22, 2014

CHICAGO — In this video, Dean Kereiakes, MD, FACC, co-principal investigator of the DAPT trial, discusses the results of the study, presented at the American Heart Association Scientific Sessions.

The trial was designed to examine whether an extended-duration dual antiplatelet therapy would reduce the incidence of stent thrombosis and major adverse CV and cerebrovascular events. No previous trial had been sufficiently powered to address this issue, Kereiakes said.

In the Journals

ARISTOTLE: Major bleeding consequences similar between apixaban, warfarin

December 22, 2014
Major bleeding was associated with increased risk for death, ischemic stroke and MI, and the risk was similarly elevated regardless of treatment with warfarin or…
Deborah Young In the JournalsPerspective

Self-reported exercise assessments offer clue to cardiometabolic risks

December 22, 2014
Clinicians could glean additional information about patients’ cardiometabolic risk factors through routine clinical physical activity assessments, according to…
Hans-Christoph Diener, MD, PhD

New trial will assess dabigatran for prevention of recurrent stroke

December 21, 2014
The first patient has been enrolled in the RE-SPECT ESUS study, which will investigate the safety of dabigatran etexilate for the prevention of recurrent embolic stroke…

CVD care improved across US hospitals from 2009 to 2013

December 20, 2014
The quality of care for patients with MI, HF, stroke and venous thromboembolism has improved across hospitals in the United States in recent years, according to an…
More News Headlines »
Risk Management in the Cardiovascular Disease Arena

Risk Management in the Cardiovascular Disease Arena: Focus on Glycemic Control

This activity is supported by an educational grant from Genentech.

Among the multiple comorbidities and complications that are associated with type 2 diabetes mellitus (T2DM)…
More »
Meeting News Coverage Video
Healio AHA2014 Bhatt1 th

VIDEO: Deepak L. Bhatt, MD, MPH, discusses 'practice-changing' IMPROVE-IT results

December 14, 2014
CHICAGO — The "practice-changing" results from the IMPROVE-IT trial presented at the American Heart Association…
More »
Lipid Forum II Highlights

Lipid Forum II Highlights

This activity is supported by an educational grant from Genentech.

Risk stratification and appropriate therapies for various dyslipidemias remain difficult concepts for practitioners…
More »